23-valent Pneumococcal Vaccine Market - Global Outlook and Forecast 2022-2028
This report contains market size and forecasts of 23-valent Pneumococcal Vaccine in global, including the following market information:
Global 23-valent Pneumococcal Vaccine Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global 23-valent Pneumococcal Vaccine Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five 23-valent Pneumococcal Vaccine companies in 2021 (%)
The global 23-valent Pneumococcal Vaccine market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Single Dose Vial Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of 23-valent Pneumococcal Vaccine include Merck, Sanofipasteur, CDIBP, Kexing Bio, Changsheng Bio-Technology and Huaan Science and Technology Innovation, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the 23-valent Pneumococcal Vaccine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global 23-valent Pneumococcal Vaccine Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global 23-valent Pneumococcal Vaccine Market Segment Percentages, by Type, 2021 (%)
Global 23-valent Pneumococcal Vaccine Market Segment Percentages, by Application, 2021 (%)
Global 23-valent Pneumococcal Vaccine Market Segment Percentages, By Region and Country, 2021 (%)
The report also provides analysis of leading market participants including:
Key companies 23-valent Pneumococcal Vaccine revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies 23-valent Pneumococcal Vaccine revenues share in global market, 2021 (%)
Key companies 23-valent Pneumococcal Vaccine sales in global market, 2017-2022 (Estimated), (K Units)
Key companies 23-valent Pneumococcal Vaccine sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Global 23-valent Pneumococcal Vaccine Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global 23-valent Pneumococcal Vaccine Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five 23-valent Pneumococcal Vaccine companies in 2021 (%)
The global 23-valent Pneumococcal Vaccine market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Single Dose Vial Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of 23-valent Pneumococcal Vaccine include Merck, Sanofipasteur, CDIBP, Kexing Bio, Changsheng Bio-Technology and Huaan Science and Technology Innovation, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the 23-valent Pneumococcal Vaccine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global 23-valent Pneumococcal Vaccine Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global 23-valent Pneumococcal Vaccine Market Segment Percentages, by Type, 2021 (%)
- Single Dose Vial
- Pre-filled Syringe
Global 23-valent Pneumococcal Vaccine Market Segment Percentages, by Application, 2021 (%)
- Chronic Cardiovascular Disease
- Chronic Lung Disease
- Chronic Liver Disease
- People Living with Hiv
- Leukemia
- Lymphoma
- Multiple Myeloma
- General Malignancy
- Chronic Kidney Disease
- Other
Global 23-valent Pneumococcal Vaccine Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
The report also provides analysis of leading market participants including:
Key companies 23-valent Pneumococcal Vaccine revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies 23-valent Pneumococcal Vaccine revenues share in global market, 2021 (%)
Key companies 23-valent Pneumococcal Vaccine sales in global market, 2017-2022 (Estimated), (K Units)
Key companies 23-valent Pneumococcal Vaccine sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Merck
- Sanofipasteur
- CDIBP
- Kexing Bio
- Changsheng Bio-Technology
- Huaan Science and Technology Innovation
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS
1.1 23-valent Pneumococcal Vaccine Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global 23-valent Pneumococcal Vaccine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL 23-VALENT PNEUMOCOCCAL VACCINE OVERALL MARKET SIZE
2.1 Global 23-valent Pneumococcal Vaccine Market Size: 2021 VS 2028
2.2 Global 23-valent Pneumococcal Vaccine Revenue, Prospects & Forecasts: 2017-2028
2.3 Global 23-valent Pneumococcal Vaccine Sales: 2017-2028
3 COMPANY LANDSCAPE
3.1 Top 23-valent Pneumococcal Vaccine Players in Global Market
3.2 Top Global 23-valent Pneumococcal Vaccine Companies Ranked by Revenue
3.3 Global 23-valent Pneumococcal Vaccine Revenue by Companies
3.4 Global 23-valent Pneumococcal Vaccine Sales by Companies
3.5 Global 23-valent Pneumococcal Vaccine Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 23-valent Pneumococcal Vaccine Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers 23-valent Pneumococcal Vaccine Product Type
3.8 Tier 1, Tier 2 and Tier 3 23-valent Pneumococcal Vaccine Players in Global Market
3.8.1 List of Global Tier 1 23-valent Pneumococcal Vaccine Companies
3.8.2 List of Global Tier 2 and Tier 3 23-valent Pneumococcal Vaccine Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Global 23-valent Pneumococcal Vaccine Market Size Markets, 2021 & 2028
4.1.2 Single Dose Vial
4.1.3 Pre-filled Syringe
4.2 By Type - Global 23-valent Pneumococcal Vaccine Revenue & Forecasts
4.2.1 By Type - Global 23-valent Pneumococcal Vaccine Revenue, 2017-2022
4.2.2 By Type - Global 23-valent Pneumococcal Vaccine Revenue, 2023-2028
4.2.3 By Type - Global 23-valent Pneumococcal Vaccine Revenue Market Share, 2017-2028
4.3 By Type - Global 23-valent Pneumococcal Vaccine Sales & Forecasts
4.3.1 By Type - Global 23-valent Pneumococcal Vaccine Sales, 2017-2022
4.3.2 By Type - Global 23-valent Pneumococcal Vaccine Sales, 2023-2028
4.3.3 By Type - Global 23-valent Pneumococcal Vaccine Sales Market Share, 2017-2028
4.4 By Type - Global 23-valent Pneumococcal Vaccine Price (Manufacturers Selling Prices), 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global 23-valent Pneumococcal Vaccine Market Size, 2021 & 2028
5.1.2 Chronic Cardiovascular Disease
5.1.3 Chronic Lung Disease
5.1.4 Chronic Liver Disease
5.1.5 People Living with Hiv
5.1.6 Leukemia
5.1.7 Lymphoma
5.1.8 Multiple Myeloma
5.1.9 General Malignancy
5.1.10 Chronic Kidney Disease
5.1.11 Other
5.2 By Application - Global 23-valent Pneumococcal Vaccine Revenue & Forecasts
5.2.1 By Application - Global 23-valent Pneumococcal Vaccine Revenue, 2017-2022
5.2.2 By Application - Global 23-valent Pneumococcal Vaccine Revenue, 2023-2028
5.2.3 By Application - Global 23-valent Pneumococcal Vaccine Revenue Market Share, 2017-2028
5.3 By Application - Global 23-valent Pneumococcal Vaccine Sales & Forecasts
5.3.1 By Application - Global 23-valent Pneumococcal Vaccine Sales, 2017-2022
5.3.2 By Application - Global 23-valent Pneumococcal Vaccine Sales, 2023-2028
5.3.3 By Application - Global 23-valent Pneumococcal Vaccine Sales Market Share, 2017-2028
5.4 By Application - Global 23-valent Pneumococcal Vaccine Price (Manufacturers Selling Prices), 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global 23-valent Pneumococcal Vaccine Market Size, 2021 & 2028
6.2 By Region - Global 23-valent Pneumococcal Vaccine Revenue & Forecasts
6.2.1 By Region - Global 23-valent Pneumococcal Vaccine Revenue, 2017-2022
6.2.2 By Region - Global 23-valent Pneumococcal Vaccine Revenue, 2023-2028
6.2.3 By Region - Global 23-valent Pneumococcal Vaccine Revenue Market Share, 2017-2028
6.3 By Region - Global 23-valent Pneumococcal Vaccine Sales & Forecasts
6.3.1 By Region - Global 23-valent Pneumococcal Vaccine Sales, 2017-2022
6.3.2 By Region - Global 23-valent Pneumococcal Vaccine Sales, 2023-2028
6.3.3 By Region - Global 23-valent Pneumococcal Vaccine Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America 23-valent Pneumococcal Vaccine Revenue, 2017-2028
6.4.2 By Country - North America 23-valent Pneumococcal Vaccine Sales, 2017-2028
6.4.3 US 23-valent Pneumococcal Vaccine Market Size, 2017-2028
6.4.4 Canada 23-valent Pneumococcal Vaccine Market Size, 2017-2028
6.4.5 Mexico 23-valent Pneumococcal Vaccine Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe 23-valent Pneumococcal Vaccine Revenue, 2017-2028
6.5.2 By Country - Europe 23-valent Pneumococcal Vaccine Sales, 2017-2028
6.5.3 Germany 23-valent Pneumococcal Vaccine Market Size, 2017-2028
6.5.4 France 23-valent Pneumococcal Vaccine Market Size, 2017-2028
6.5.5 U.K. 23-valent Pneumococcal Vaccine Market Size, 2017-2028
6.5.6 Italy 23-valent Pneumococcal Vaccine Market Size, 2017-2028
6.5.7 Russia 23-valent Pneumococcal Vaccine Market Size, 2017-2028
6.5.8 Nordic Countries 23-valent Pneumococcal Vaccine Market Size, 2017-2028
6.5.9 Benelux 23-valent Pneumococcal Vaccine Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia 23-valent Pneumococcal Vaccine Revenue, 2017-2028
6.6.2 By Region - Asia 23-valent Pneumococcal Vaccine Sales, 2017-2028
6.6.3 China 23-valent Pneumococcal Vaccine Market Size, 2017-2028
6.6.4 Japan 23-valent Pneumococcal Vaccine Market Size, 2017-2028
6.6.5 South Korea 23-valent Pneumococcal Vaccine Market Size, 2017-2028
6.6.6 Southeast Asia 23-valent Pneumococcal Vaccine Market Size, 2017-2028
6.6.7 India 23-valent Pneumococcal Vaccine Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America 23-valent Pneumococcal Vaccine Revenue, 2017-2028
6.7.2 By Country - South America 23-valent Pneumococcal Vaccine Sales, 2017-2028
6.7.3 Brazil 23-valent Pneumococcal Vaccine Market Size, 2017-2028
6.7.4 Argentina 23-valent Pneumococcal Vaccine Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa 23-valent Pneumococcal Vaccine Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa 23-valent Pneumococcal Vaccine Sales, 2017-2028
6.8.3 Turkey 23-valent Pneumococcal Vaccine Market Size, 2017-2028
6.8.4 Israel 23-valent Pneumococcal Vaccine Market Size, 2017-2028
6.8.5 Saudi Arabia 23-valent Pneumococcal Vaccine Market Size, 2017-2028
6.8.6 UAE 23-valent Pneumococcal Vaccine Market Size, 2017-2028
7 MANUFACTURERS & BRANDS PROFILES
7.1 Merck
7.1.1 Merck Corporate Summary
7.1.2 Merck Business Overview
7.1.3 Merck 23-valent Pneumococcal Vaccine Major Product Offerings
7.1.4 Merck 23-valent Pneumococcal Vaccine Sales and Revenue in Global (2017-2022)
7.1.5 Merck Key News
7.2 Sanofipasteur
7.2.1 Sanofipasteur Corporate Summary
7.2.2 Sanofipasteur Business Overview
7.2.3 Sanofipasteur 23-valent Pneumococcal Vaccine Major Product Offerings
7.2.4 Sanofipasteur 23-valent Pneumococcal Vaccine Sales and Revenue in Global (2017-2022)
7.2.5 Sanofipasteur Key News
7.3 CDIBP
7.3.1 CDIBP Corporate Summary
7.3.2 CDIBP Business Overview
7.3.3 CDIBP 23-valent Pneumococcal Vaccine Major Product Offerings
7.3.4 CDIBP 23-valent Pneumococcal Vaccine Sales and Revenue in Global (2017-2022)
7.3.5 CDIBP Key News
7.4 Kexing Bio
7.4.1 Kexing Bio Corporate Summary
7.4.2 Kexing Bio Business Overview
7.4.3 Kexing Bio 23-valent Pneumococcal Vaccine Major Product Offerings
7.4.4 Kexing Bio 23-valent Pneumococcal Vaccine Sales and Revenue in Global (2017-2022)
7.4.5 Kexing Bio Key News
7.5 Changsheng Bio-Technology
7.5.1 Changsheng Bio-Technology Corporate Summary
7.5.2 Changsheng Bio-Technology Business Overview
7.5.3 Changsheng Bio-Technology 23-valent Pneumococcal Vaccine Major Product Offerings
7.5.4 Changsheng Bio-Technology 23-valent Pneumococcal Vaccine Sales and Revenue in Global (2017-2022)
7.5.5 Changsheng Bio-Technology Key News
7.6 Huaan Science and Technology Innovation
7.6.1 Huaan Science and Technology Innovation Corporate Summary
7.6.2 Huaan Science and Technology Innovation Business Overview
7.6.3 Huaan Science and Technology Innovation 23-valent Pneumococcal Vaccine Major Product Offerings
7.6.4 Huaan Science and Technology Innovation 23-valent Pneumococcal Vaccine Sales and Revenue in Global (2017-2022)
7.6.5 Huaan Science and Technology Innovation Key News
8 GLOBAL 23-VALENT PNEUMOCOCCAL VACCINE PRODUCTION CAPACITY, ANALYSIS
8.1 Global 23-valent Pneumococcal Vaccine Production Capacity, 2017-2028
8.2 23-valent Pneumococcal Vaccine Production Capacity of Key Manufacturers in Global Market
8.3 Global 23-valent Pneumococcal Vaccine Production by Region
9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 23-VALENT PNEUMOCOCCAL VACCINE SUPPLY CHAIN ANALYSIS
10.1 23-valent Pneumococcal Vaccine Industry Value Chain
10.2 23-valent Pneumococcal Vaccine Upstream Market
10.3 23-valent Pneumococcal Vaccine Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 23-valent Pneumococcal Vaccine Distributors and Sales Agents in Global
11 CONCLUSION
12 APPENDIX
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
1.1 23-valent Pneumococcal Vaccine Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global 23-valent Pneumococcal Vaccine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL 23-VALENT PNEUMOCOCCAL VACCINE OVERALL MARKET SIZE
2.1 Global 23-valent Pneumococcal Vaccine Market Size: 2021 VS 2028
2.2 Global 23-valent Pneumococcal Vaccine Revenue, Prospects & Forecasts: 2017-2028
2.3 Global 23-valent Pneumococcal Vaccine Sales: 2017-2028
3 COMPANY LANDSCAPE
3.1 Top 23-valent Pneumococcal Vaccine Players in Global Market
3.2 Top Global 23-valent Pneumococcal Vaccine Companies Ranked by Revenue
3.3 Global 23-valent Pneumococcal Vaccine Revenue by Companies
3.4 Global 23-valent Pneumococcal Vaccine Sales by Companies
3.5 Global 23-valent Pneumococcal Vaccine Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 23-valent Pneumococcal Vaccine Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers 23-valent Pneumococcal Vaccine Product Type
3.8 Tier 1, Tier 2 and Tier 3 23-valent Pneumococcal Vaccine Players in Global Market
3.8.1 List of Global Tier 1 23-valent Pneumococcal Vaccine Companies
3.8.2 List of Global Tier 2 and Tier 3 23-valent Pneumococcal Vaccine Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Global 23-valent Pneumococcal Vaccine Market Size Markets, 2021 & 2028
4.1.2 Single Dose Vial
4.1.3 Pre-filled Syringe
4.2 By Type - Global 23-valent Pneumococcal Vaccine Revenue & Forecasts
4.2.1 By Type - Global 23-valent Pneumococcal Vaccine Revenue, 2017-2022
4.2.2 By Type - Global 23-valent Pneumococcal Vaccine Revenue, 2023-2028
4.2.3 By Type - Global 23-valent Pneumococcal Vaccine Revenue Market Share, 2017-2028
4.3 By Type - Global 23-valent Pneumococcal Vaccine Sales & Forecasts
4.3.1 By Type - Global 23-valent Pneumococcal Vaccine Sales, 2017-2022
4.3.2 By Type - Global 23-valent Pneumococcal Vaccine Sales, 2023-2028
4.3.3 By Type - Global 23-valent Pneumococcal Vaccine Sales Market Share, 2017-2028
4.4 By Type - Global 23-valent Pneumococcal Vaccine Price (Manufacturers Selling Prices), 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global 23-valent Pneumococcal Vaccine Market Size, 2021 & 2028
5.1.2 Chronic Cardiovascular Disease
5.1.3 Chronic Lung Disease
5.1.4 Chronic Liver Disease
5.1.5 People Living with Hiv
5.1.6 Leukemia
5.1.7 Lymphoma
5.1.8 Multiple Myeloma
5.1.9 General Malignancy
5.1.10 Chronic Kidney Disease
5.1.11 Other
5.2 By Application - Global 23-valent Pneumococcal Vaccine Revenue & Forecasts
5.2.1 By Application - Global 23-valent Pneumococcal Vaccine Revenue, 2017-2022
5.2.2 By Application - Global 23-valent Pneumococcal Vaccine Revenue, 2023-2028
5.2.3 By Application - Global 23-valent Pneumococcal Vaccine Revenue Market Share, 2017-2028
5.3 By Application - Global 23-valent Pneumococcal Vaccine Sales & Forecasts
5.3.1 By Application - Global 23-valent Pneumococcal Vaccine Sales, 2017-2022
5.3.2 By Application - Global 23-valent Pneumococcal Vaccine Sales, 2023-2028
5.3.3 By Application - Global 23-valent Pneumococcal Vaccine Sales Market Share, 2017-2028
5.4 By Application - Global 23-valent Pneumococcal Vaccine Price (Manufacturers Selling Prices), 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global 23-valent Pneumococcal Vaccine Market Size, 2021 & 2028
6.2 By Region - Global 23-valent Pneumococcal Vaccine Revenue & Forecasts
6.2.1 By Region - Global 23-valent Pneumococcal Vaccine Revenue, 2017-2022
6.2.2 By Region - Global 23-valent Pneumococcal Vaccine Revenue, 2023-2028
6.2.3 By Region - Global 23-valent Pneumococcal Vaccine Revenue Market Share, 2017-2028
6.3 By Region - Global 23-valent Pneumococcal Vaccine Sales & Forecasts
6.3.1 By Region - Global 23-valent Pneumococcal Vaccine Sales, 2017-2022
6.3.2 By Region - Global 23-valent Pneumococcal Vaccine Sales, 2023-2028
6.3.3 By Region - Global 23-valent Pneumococcal Vaccine Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America 23-valent Pneumococcal Vaccine Revenue, 2017-2028
6.4.2 By Country - North America 23-valent Pneumococcal Vaccine Sales, 2017-2028
6.4.3 US 23-valent Pneumococcal Vaccine Market Size, 2017-2028
6.4.4 Canada 23-valent Pneumococcal Vaccine Market Size, 2017-2028
6.4.5 Mexico 23-valent Pneumococcal Vaccine Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe 23-valent Pneumococcal Vaccine Revenue, 2017-2028
6.5.2 By Country - Europe 23-valent Pneumococcal Vaccine Sales, 2017-2028
6.5.3 Germany 23-valent Pneumococcal Vaccine Market Size, 2017-2028
6.5.4 France 23-valent Pneumococcal Vaccine Market Size, 2017-2028
6.5.5 U.K. 23-valent Pneumococcal Vaccine Market Size, 2017-2028
6.5.6 Italy 23-valent Pneumococcal Vaccine Market Size, 2017-2028
6.5.7 Russia 23-valent Pneumococcal Vaccine Market Size, 2017-2028
6.5.8 Nordic Countries 23-valent Pneumococcal Vaccine Market Size, 2017-2028
6.5.9 Benelux 23-valent Pneumococcal Vaccine Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia 23-valent Pneumococcal Vaccine Revenue, 2017-2028
6.6.2 By Region - Asia 23-valent Pneumococcal Vaccine Sales, 2017-2028
6.6.3 China 23-valent Pneumococcal Vaccine Market Size, 2017-2028
6.6.4 Japan 23-valent Pneumococcal Vaccine Market Size, 2017-2028
6.6.5 South Korea 23-valent Pneumococcal Vaccine Market Size, 2017-2028
6.6.6 Southeast Asia 23-valent Pneumococcal Vaccine Market Size, 2017-2028
6.6.7 India 23-valent Pneumococcal Vaccine Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America 23-valent Pneumococcal Vaccine Revenue, 2017-2028
6.7.2 By Country - South America 23-valent Pneumococcal Vaccine Sales, 2017-2028
6.7.3 Brazil 23-valent Pneumococcal Vaccine Market Size, 2017-2028
6.7.4 Argentina 23-valent Pneumococcal Vaccine Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa 23-valent Pneumococcal Vaccine Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa 23-valent Pneumococcal Vaccine Sales, 2017-2028
6.8.3 Turkey 23-valent Pneumococcal Vaccine Market Size, 2017-2028
6.8.4 Israel 23-valent Pneumococcal Vaccine Market Size, 2017-2028
6.8.5 Saudi Arabia 23-valent Pneumococcal Vaccine Market Size, 2017-2028
6.8.6 UAE 23-valent Pneumococcal Vaccine Market Size, 2017-2028
7 MANUFACTURERS & BRANDS PROFILES
7.1 Merck
7.1.1 Merck Corporate Summary
7.1.2 Merck Business Overview
7.1.3 Merck 23-valent Pneumococcal Vaccine Major Product Offerings
7.1.4 Merck 23-valent Pneumococcal Vaccine Sales and Revenue in Global (2017-2022)
7.1.5 Merck Key News
7.2 Sanofipasteur
7.2.1 Sanofipasteur Corporate Summary
7.2.2 Sanofipasteur Business Overview
7.2.3 Sanofipasteur 23-valent Pneumococcal Vaccine Major Product Offerings
7.2.4 Sanofipasteur 23-valent Pneumococcal Vaccine Sales and Revenue in Global (2017-2022)
7.2.5 Sanofipasteur Key News
7.3 CDIBP
7.3.1 CDIBP Corporate Summary
7.3.2 CDIBP Business Overview
7.3.3 CDIBP 23-valent Pneumococcal Vaccine Major Product Offerings
7.3.4 CDIBP 23-valent Pneumococcal Vaccine Sales and Revenue in Global (2017-2022)
7.3.5 CDIBP Key News
7.4 Kexing Bio
7.4.1 Kexing Bio Corporate Summary
7.4.2 Kexing Bio Business Overview
7.4.3 Kexing Bio 23-valent Pneumococcal Vaccine Major Product Offerings
7.4.4 Kexing Bio 23-valent Pneumococcal Vaccine Sales and Revenue in Global (2017-2022)
7.4.5 Kexing Bio Key News
7.5 Changsheng Bio-Technology
7.5.1 Changsheng Bio-Technology Corporate Summary
7.5.2 Changsheng Bio-Technology Business Overview
7.5.3 Changsheng Bio-Technology 23-valent Pneumococcal Vaccine Major Product Offerings
7.5.4 Changsheng Bio-Technology 23-valent Pneumococcal Vaccine Sales and Revenue in Global (2017-2022)
7.5.5 Changsheng Bio-Technology Key News
7.6 Huaan Science and Technology Innovation
7.6.1 Huaan Science and Technology Innovation Corporate Summary
7.6.2 Huaan Science and Technology Innovation Business Overview
7.6.3 Huaan Science and Technology Innovation 23-valent Pneumococcal Vaccine Major Product Offerings
7.6.4 Huaan Science and Technology Innovation 23-valent Pneumococcal Vaccine Sales and Revenue in Global (2017-2022)
7.6.5 Huaan Science and Technology Innovation Key News
8 GLOBAL 23-VALENT PNEUMOCOCCAL VACCINE PRODUCTION CAPACITY, ANALYSIS
8.1 Global 23-valent Pneumococcal Vaccine Production Capacity, 2017-2028
8.2 23-valent Pneumococcal Vaccine Production Capacity of Key Manufacturers in Global Market
8.3 Global 23-valent Pneumococcal Vaccine Production by Region
9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 23-VALENT PNEUMOCOCCAL VACCINE SUPPLY CHAIN ANALYSIS
10.1 23-valent Pneumococcal Vaccine Industry Value Chain
10.2 23-valent Pneumococcal Vaccine Upstream Market
10.3 23-valent Pneumococcal Vaccine Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 23-valent Pneumococcal Vaccine Distributors and Sales Agents in Global
11 CONCLUSION
12 APPENDIX
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES
Table 1. Key Players of 23-valent Pneumococcal Vaccine in Global Market
Table 2. Top 23-valent Pneumococcal Vaccine Players in Global Market, Ranking by Revenue (2021)
Table 3. Global 23-valent Pneumococcal Vaccine Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global 23-valent Pneumococcal Vaccine Revenue Share by Companies, 2017-2022
Table 5. Global 23-valent Pneumococcal Vaccine Sales by Companies, (K Units), 2017-2022
Table 6. Global 23-valent Pneumococcal Vaccine Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers 23-valent Pneumococcal Vaccine Price (2017-2022) & (US$/Unit)
Table 8. Global Manufacturers 23-valent Pneumococcal Vaccine Product Type
Table 9. List of Global Tier 1 23-valent Pneumococcal Vaccine Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 23-valent Pneumococcal Vaccine Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global 23-valent Pneumococcal Vaccine Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global 23-valent Pneumococcal Vaccine Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global 23-valent Pneumococcal Vaccine Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global 23-valent Pneumococcal Vaccine Sales (K Units), 2017-2022
Table 15. By Type - Global 23-valent Pneumococcal Vaccine Sales (K Units), 2023-2028
Table 16. By Application – Global 23-valent Pneumococcal Vaccine Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global 23-valent Pneumococcal Vaccine Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global 23-valent Pneumococcal Vaccine Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global 23-valent Pneumococcal Vaccine Sales (K Units), 2017-2022
Table 20. By Application - Global 23-valent Pneumococcal Vaccine Sales (K Units), 2023-2028
Table 21. By Region – Global 23-valent Pneumococcal Vaccine Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global 23-valent Pneumococcal Vaccine Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global 23-valent Pneumococcal Vaccine Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global 23-valent Pneumococcal Vaccine Sales (K Units), 2017-2022
Table 25. By Region - Global 23-valent Pneumococcal Vaccine Sales (K Units), 2023-2028
Table 26. By Country - North America 23-valent Pneumococcal Vaccine Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America 23-valent Pneumococcal Vaccine Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America 23-valent Pneumococcal Vaccine Sales, (K Units), 2017-2022
Table 29. By Country - North America 23-valent Pneumococcal Vaccine Sales, (K Units), 2023-2028
Table 30. By Country - Europe 23-valent Pneumococcal Vaccine Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe 23-valent Pneumococcal Vaccine Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe 23-valent Pneumococcal Vaccine Sales, (K Units), 2017-2022
Table 33. By Country - Europe 23-valent Pneumococcal Vaccine Sales, (K Units), 2023-2028
Table 34. By Region - Asia 23-valent Pneumococcal Vaccine Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia 23-valent Pneumococcal Vaccine Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia 23-valent Pneumococcal Vaccine Sales, (K Units), 2017-2022
Table 37. By Region - Asia 23-valent Pneumococcal Vaccine Sales, (K Units), 2023-2028
Table 38. By Country - South America 23-valent Pneumococcal Vaccine Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America 23-valent Pneumococcal Vaccine Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America 23-valent Pneumococcal Vaccine Sales, (K Units), 2017-2022
Table 41. By Country - South America 23-valent Pneumococcal Vaccine Sales, (K Units), 2023-2028
Table 42. By Country - Middle East & Africa 23-valent Pneumococcal Vaccine Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa 23-valent Pneumococcal Vaccine Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa 23-valent Pneumococcal Vaccine Sales, (K Units), 2017-2022
Table 45. By Country - Middle East & Africa 23-valent Pneumococcal Vaccine Sales, (K Units), 2023-2028
Table 46. Merck Corporate Summary
Table 47. Merck 23-valent Pneumococcal Vaccine Product Offerings
Table 48. Merck 23-valent Pneumococcal Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 49. Sanofipasteur Corporate Summary
Table 50. Sanofipasteur 23-valent Pneumococcal Vaccine Product Offerings
Table 51. Sanofipasteur 23-valent Pneumococcal Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 52. CDIBP Corporate Summary
Table 53. CDIBP 23-valent Pneumococcal Vaccine Product Offerings
Table 54. CDIBP 23-valent Pneumococcal Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 55. Kexing Bio Corporate Summary
Table 56. Kexing Bio 23-valent Pneumococcal Vaccine Product Offerings
Table 57. Kexing Bio 23-valent Pneumococcal Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 58. Changsheng Bio-Technology Corporate Summary
Table 59. Changsheng Bio-Technology 23-valent Pneumococcal Vaccine Product Offerings
Table 60. Changsheng Bio-Technology 23-valent Pneumococcal Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 61. Huaan Science and Technology Innovation Corporate Summary
Table 62. Huaan Science and Technology Innovation 23-valent Pneumococcal Vaccine Product Offerings
Table 63. Huaan Science and Technology Innovation 23-valent Pneumococcal Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 64. 23-valent Pneumococcal Vaccine Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
Table 65. Global 23-valent Pneumococcal Vaccine Capacity Market Share of Key Manufacturers, 2020-2022
Table 66. Global 23-valent Pneumococcal Vaccine Production by Region, 2017-2022 (K Units)
Table 67. Global 23-valent Pneumococcal Vaccine Production by Region, 2023-2028 (K Units)
Table 68. 23-valent Pneumococcal Vaccine Market Opportunities & Trends in Global Market
Table 69. 23-valent Pneumococcal Vaccine Market Drivers in Global Market
Table 70. 23-valent Pneumococcal Vaccine Market Restraints in Global Market
Table 71. 23-valent Pneumococcal Vaccine Raw Materials
Table 72. 23-valent Pneumococcal Vaccine Raw Materials Suppliers in Global Market
Table 73. Typical 23-valent Pneumococcal Vaccine Downstream
Table 74. 23-valent Pneumococcal Vaccine Downstream Clients in Global Market
Table 75. 23-valent Pneumococcal Vaccine Distributors and Sales Agents in Global Market
Table 1. Key Players of 23-valent Pneumococcal Vaccine in Global Market
Table 2. Top 23-valent Pneumococcal Vaccine Players in Global Market, Ranking by Revenue (2021)
Table 3. Global 23-valent Pneumococcal Vaccine Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global 23-valent Pneumococcal Vaccine Revenue Share by Companies, 2017-2022
Table 5. Global 23-valent Pneumococcal Vaccine Sales by Companies, (K Units), 2017-2022
Table 6. Global 23-valent Pneumococcal Vaccine Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers 23-valent Pneumococcal Vaccine Price (2017-2022) & (US$/Unit)
Table 8. Global Manufacturers 23-valent Pneumococcal Vaccine Product Type
Table 9. List of Global Tier 1 23-valent Pneumococcal Vaccine Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 23-valent Pneumococcal Vaccine Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global 23-valent Pneumococcal Vaccine Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global 23-valent Pneumococcal Vaccine Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global 23-valent Pneumococcal Vaccine Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global 23-valent Pneumococcal Vaccine Sales (K Units), 2017-2022
Table 15. By Type - Global 23-valent Pneumococcal Vaccine Sales (K Units), 2023-2028
Table 16. By Application – Global 23-valent Pneumococcal Vaccine Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global 23-valent Pneumococcal Vaccine Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global 23-valent Pneumococcal Vaccine Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global 23-valent Pneumococcal Vaccine Sales (K Units), 2017-2022
Table 20. By Application - Global 23-valent Pneumococcal Vaccine Sales (K Units), 2023-2028
Table 21. By Region – Global 23-valent Pneumococcal Vaccine Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global 23-valent Pneumococcal Vaccine Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global 23-valent Pneumococcal Vaccine Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global 23-valent Pneumococcal Vaccine Sales (K Units), 2017-2022
Table 25. By Region - Global 23-valent Pneumococcal Vaccine Sales (K Units), 2023-2028
Table 26. By Country - North America 23-valent Pneumococcal Vaccine Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America 23-valent Pneumococcal Vaccine Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America 23-valent Pneumococcal Vaccine Sales, (K Units), 2017-2022
Table 29. By Country - North America 23-valent Pneumococcal Vaccine Sales, (K Units), 2023-2028
Table 30. By Country - Europe 23-valent Pneumococcal Vaccine Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe 23-valent Pneumococcal Vaccine Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe 23-valent Pneumococcal Vaccine Sales, (K Units), 2017-2022
Table 33. By Country - Europe 23-valent Pneumococcal Vaccine Sales, (K Units), 2023-2028
Table 34. By Region - Asia 23-valent Pneumococcal Vaccine Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia 23-valent Pneumococcal Vaccine Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia 23-valent Pneumococcal Vaccine Sales, (K Units), 2017-2022
Table 37. By Region - Asia 23-valent Pneumococcal Vaccine Sales, (K Units), 2023-2028
Table 38. By Country - South America 23-valent Pneumococcal Vaccine Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America 23-valent Pneumococcal Vaccine Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America 23-valent Pneumococcal Vaccine Sales, (K Units), 2017-2022
Table 41. By Country - South America 23-valent Pneumococcal Vaccine Sales, (K Units), 2023-2028
Table 42. By Country - Middle East & Africa 23-valent Pneumococcal Vaccine Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa 23-valent Pneumococcal Vaccine Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa 23-valent Pneumococcal Vaccine Sales, (K Units), 2017-2022
Table 45. By Country - Middle East & Africa 23-valent Pneumococcal Vaccine Sales, (K Units), 2023-2028
Table 46. Merck Corporate Summary
Table 47. Merck 23-valent Pneumococcal Vaccine Product Offerings
Table 48. Merck 23-valent Pneumococcal Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 49. Sanofipasteur Corporate Summary
Table 50. Sanofipasteur 23-valent Pneumococcal Vaccine Product Offerings
Table 51. Sanofipasteur 23-valent Pneumococcal Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 52. CDIBP Corporate Summary
Table 53. CDIBP 23-valent Pneumococcal Vaccine Product Offerings
Table 54. CDIBP 23-valent Pneumococcal Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 55. Kexing Bio Corporate Summary
Table 56. Kexing Bio 23-valent Pneumococcal Vaccine Product Offerings
Table 57. Kexing Bio 23-valent Pneumococcal Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 58. Changsheng Bio-Technology Corporate Summary
Table 59. Changsheng Bio-Technology 23-valent Pneumococcal Vaccine Product Offerings
Table 60. Changsheng Bio-Technology 23-valent Pneumococcal Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 61. Huaan Science and Technology Innovation Corporate Summary
Table 62. Huaan Science and Technology Innovation 23-valent Pneumococcal Vaccine Product Offerings
Table 63. Huaan Science and Technology Innovation 23-valent Pneumococcal Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 64. 23-valent Pneumococcal Vaccine Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
Table 65. Global 23-valent Pneumococcal Vaccine Capacity Market Share of Key Manufacturers, 2020-2022
Table 66. Global 23-valent Pneumococcal Vaccine Production by Region, 2017-2022 (K Units)
Table 67. Global 23-valent Pneumococcal Vaccine Production by Region, 2023-2028 (K Units)
Table 68. 23-valent Pneumococcal Vaccine Market Opportunities & Trends in Global Market
Table 69. 23-valent Pneumococcal Vaccine Market Drivers in Global Market
Table 70. 23-valent Pneumococcal Vaccine Market Restraints in Global Market
Table 71. 23-valent Pneumococcal Vaccine Raw Materials
Table 72. 23-valent Pneumococcal Vaccine Raw Materials Suppliers in Global Market
Table 73. Typical 23-valent Pneumococcal Vaccine Downstream
Table 74. 23-valent Pneumococcal Vaccine Downstream Clients in Global Market
Table 75. 23-valent Pneumococcal Vaccine Distributors and Sales Agents in Global Market
LIST OF FIGURES
Figure 1. 23-valent Pneumococcal Vaccine Segment by Type
Figure 2. 23-valent Pneumococcal Vaccine Segment by Application
Figure 3. Global 23-valent Pneumococcal Vaccine Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global 23-valent Pneumococcal Vaccine Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global 23-valent Pneumococcal Vaccine Revenue, 2017-2028 (US$, Mn)
Figure 7. 23-valent Pneumococcal Vaccine Sales in Global Market: 2017-2028 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by 23-valent Pneumococcal Vaccine Revenue in 2021
Figure 9. By Type - Global 23-valent Pneumococcal Vaccine Sales Market Share, 2017-2028
Figure 10. By Type - Global 23-valent Pneumococcal Vaccine Revenue Market Share, 2017-2028
Figure 11. By Type - Global 23-valent Pneumococcal Vaccine Price (US$/Unit), 2017-2028
Figure 12. By Application - Global 23-valent Pneumococcal Vaccine Sales Market Share, 2017-2028
Figure 13. By Application - Global 23-valent Pneumococcal Vaccine Revenue Market Share, 2017-2028
Figure 14. By Application - Global 23-valent Pneumococcal Vaccine Price (US$/Unit), 2017-2028
Figure 15. By Region - Global 23-valent Pneumococcal Vaccine Sales Market Share, 2017-2028
Figure 16. By Region - Global 23-valent Pneumococcal Vaccine Revenue Market Share, 2017-2028
Figure 17. By Country - North America 23-valent Pneumococcal Vaccine Revenue Market Share, 2017-2028
Figure 18. By Country - North America 23-valent Pneumococcal Vaccine Sales Market Share, 2017-2028
Figure 19. US 23-valent Pneumococcal Vaccine Revenue, (US$, Mn), 2017-2028
Figure 20. Canada 23-valent Pneumococcal Vaccine Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico 23-valent Pneumococcal Vaccine Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe 23-valent Pneumococcal Vaccine Revenue Market Share, 2017-2028
Figure 23. By Country - Europe 23-valent Pneumococcal Vaccine Sales Market Share, 2017-2028
Figure 24. Germany 23-valent Pneumococcal Vaccine Revenue, (US$, Mn), 2017-2028
Figure 25. France 23-valent Pneumococcal Vaccine Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. 23-valent Pneumococcal Vaccine Revenue, (US$, Mn), 2017-2028
Figure 27. Italy 23-valent Pneumococcal Vaccine Revenue, (US$, Mn), 2017-2028
Figure 28. Russia 23-valent Pneumococcal Vaccine Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries 23-valent Pneumococcal Vaccine Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux 23-valent Pneumococcal Vaccine Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia 23-valent Pneumococcal Vaccine Revenue Market Share, 2017-2028
Figure 32. By Region - Asia 23-valent Pneumococcal Vaccine Sales Market Share, 2017-2028
Figure 33. China 23-valent Pneumococcal Vaccine Revenue, (US$, Mn), 2017-2028
Figure 34. Japan 23-valent Pneumococcal Vaccine Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea 23-valent Pneumococcal Vaccine Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia 23-valent Pneumococcal Vaccine Revenue, (US$, Mn), 2017-2028
Figure 37. India 23-valent Pneumococcal Vaccine Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America 23-valent Pneumococcal Vaccine Revenue Market Share, 2017-2028
Figure 39. By Country - South America 23-valent Pneumococcal Vaccine Sales Market Share, 2017-2028
Figure 40. Brazil 23-valent Pneumococcal Vaccine Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina 23-valent Pneumococcal Vaccine Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa 23-valent Pneumococcal Vaccine Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa 23-valent Pneumococcal Vaccine Sales Market Share, 2017-2028
Figure 44. Turkey 23-valent Pneumococcal Vaccine Revenue, (US$, Mn), 2017-2028
Figure 45. Israel 23-valent Pneumococcal Vaccine Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia 23-valent Pneumococcal Vaccine Revenue, (US$, Mn), 2017-2028
Figure 47. UAE 23-valent Pneumococcal Vaccine Revenue, (US$, Mn), 2017-2028
Figure 48. Global 23-valent Pneumococcal Vaccine Production Capacity (K Units), 2017-2028
Figure 49. The Percentage of Production 23-valent Pneumococcal Vaccine by Region, 2021 VS 2028
Figure 50. 23-valent Pneumococcal Vaccine Industry Value Chain
Figure 51. Marketing Channels
Figure 1. 23-valent Pneumococcal Vaccine Segment by Type
Figure 2. 23-valent Pneumococcal Vaccine Segment by Application
Figure 3. Global 23-valent Pneumococcal Vaccine Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global 23-valent Pneumococcal Vaccine Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global 23-valent Pneumococcal Vaccine Revenue, 2017-2028 (US$, Mn)
Figure 7. 23-valent Pneumococcal Vaccine Sales in Global Market: 2017-2028 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by 23-valent Pneumococcal Vaccine Revenue in 2021
Figure 9. By Type - Global 23-valent Pneumococcal Vaccine Sales Market Share, 2017-2028
Figure 10. By Type - Global 23-valent Pneumococcal Vaccine Revenue Market Share, 2017-2028
Figure 11. By Type - Global 23-valent Pneumococcal Vaccine Price (US$/Unit), 2017-2028
Figure 12. By Application - Global 23-valent Pneumococcal Vaccine Sales Market Share, 2017-2028
Figure 13. By Application - Global 23-valent Pneumococcal Vaccine Revenue Market Share, 2017-2028
Figure 14. By Application - Global 23-valent Pneumococcal Vaccine Price (US$/Unit), 2017-2028
Figure 15. By Region - Global 23-valent Pneumococcal Vaccine Sales Market Share, 2017-2028
Figure 16. By Region - Global 23-valent Pneumococcal Vaccine Revenue Market Share, 2017-2028
Figure 17. By Country - North America 23-valent Pneumococcal Vaccine Revenue Market Share, 2017-2028
Figure 18. By Country - North America 23-valent Pneumococcal Vaccine Sales Market Share, 2017-2028
Figure 19. US 23-valent Pneumococcal Vaccine Revenue, (US$, Mn), 2017-2028
Figure 20. Canada 23-valent Pneumococcal Vaccine Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico 23-valent Pneumococcal Vaccine Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe 23-valent Pneumococcal Vaccine Revenue Market Share, 2017-2028
Figure 23. By Country - Europe 23-valent Pneumococcal Vaccine Sales Market Share, 2017-2028
Figure 24. Germany 23-valent Pneumococcal Vaccine Revenue, (US$, Mn), 2017-2028
Figure 25. France 23-valent Pneumococcal Vaccine Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. 23-valent Pneumococcal Vaccine Revenue, (US$, Mn), 2017-2028
Figure 27. Italy 23-valent Pneumococcal Vaccine Revenue, (US$, Mn), 2017-2028
Figure 28. Russia 23-valent Pneumococcal Vaccine Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries 23-valent Pneumococcal Vaccine Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux 23-valent Pneumococcal Vaccine Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia 23-valent Pneumococcal Vaccine Revenue Market Share, 2017-2028
Figure 32. By Region - Asia 23-valent Pneumococcal Vaccine Sales Market Share, 2017-2028
Figure 33. China 23-valent Pneumococcal Vaccine Revenue, (US$, Mn), 2017-2028
Figure 34. Japan 23-valent Pneumococcal Vaccine Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea 23-valent Pneumococcal Vaccine Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia 23-valent Pneumococcal Vaccine Revenue, (US$, Mn), 2017-2028
Figure 37. India 23-valent Pneumococcal Vaccine Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America 23-valent Pneumococcal Vaccine Revenue Market Share, 2017-2028
Figure 39. By Country - South America 23-valent Pneumococcal Vaccine Sales Market Share, 2017-2028
Figure 40. Brazil 23-valent Pneumococcal Vaccine Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina 23-valent Pneumococcal Vaccine Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa 23-valent Pneumococcal Vaccine Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa 23-valent Pneumococcal Vaccine Sales Market Share, 2017-2028
Figure 44. Turkey 23-valent Pneumococcal Vaccine Revenue, (US$, Mn), 2017-2028
Figure 45. Israel 23-valent Pneumococcal Vaccine Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia 23-valent Pneumococcal Vaccine Revenue, (US$, Mn), 2017-2028
Figure 47. UAE 23-valent Pneumococcal Vaccine Revenue, (US$, Mn), 2017-2028
Figure 48. Global 23-valent Pneumococcal Vaccine Production Capacity (K Units), 2017-2028
Figure 49. The Percentage of Production 23-valent Pneumococcal Vaccine by Region, 2021 VS 2028
Figure 50. 23-valent Pneumococcal Vaccine Industry Value Chain
Figure 51. Marketing Channels
